Profit and Loss Results Results Snapshot
Figures in Million
Consolidated - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
No of Months
12
12
12
12
12
12
Operating Income
969.00
816.00
794.00
647.00
602.00
576.00
Less :Inter divisional transfers
0.00
0.00
0.00
0.00
0.00
0.00
Less: Excise
0.00
0.00
0.00
0.00
0.00
0.00
Net Sales
969.00
816.00
794.00
647.00
602.00
576.00
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
Raw Materials Consumed
0.00
0.00
0.00
0.00
0.00
0.00
Power & Fuel Cost
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
Operating Expenses
1.00
1.00
1.00
0.00
0.00
0.00
General and Administration Expenses
299.00
274.00
295.00
310.00
320.00
494.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Cost of Software developments
0.00
0.00
0.00
0.00
0.00
0.00
Miscellaneous Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
0.00
Total Expenditure
760.00
705.00
742.00
769.00
843.00
1,172.00
Operating Profit (PBDIT) excl Other Income
209.00
110.00
51.00
-122.00
-240.00
-595.00
Other Income
1.00
15.00
-144.00
-143.00
-69.00
-69.00
Operating Profit (PBDIT)
226.00
128.00
-107.00
-265.00
-310.00
-664.00
Interest
1.00
1.00
1.00
0.00
0.00
0.00
Profit before Depriciation and Tax
0.00
0.00
0.00
0.00
0.00
0.00
Depreciation
15.00
2.00
0.00
0.00
0.00
0.00
Profit Before Taxation & Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
Exceptional Income / Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Profit Before Tax
209.00
124.00
-280.00
-250.00
-310.00
-658.00
Provision for Tax
-39.00
-62.00
9.00
8.00
8.00
9.00
Profit After Tax
249.00
186.00
-289.00
-258.00
-318.00
-668.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Adj to Profit After Tax
0.00
0.00
0.00
0.00
0.00
0.00
Profit Balance B/F
0.00
0.00
0.00
0.00
0.00
0.00
Profit Available for appropriations
0.00
0.00
0.00
0.00
0.00
0.00
Appropriations
0.00
0.00
0.00
0.00
0.00
0.00
Equity Dividend (%)
Earnings Per Share
26.74
20.05
-31.11
-27.78
-34.23
-76.01
Profit And Loss Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2025 is 18.71% vs 2.78% in Mar 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2025 is 88.61% vs 114.79% in Mar 2024
Interest
YoY Growth in year ended Mar 2025 is 11.50% vs 5.31% in Mar 2024
Profit After Tax
YoY Growth in year ended Mar 2025 is 33.40% vs 164.44% in Mar 2024
Compare Profit and Loss Results of Immuno-Biological Laboratories Co., Ltd.
Figures in Million
consolidated - Profit And Loss Results
Change(JPY)
Change(%)
No of Months
12
12
Operating Income
969.00
32,908.00
-31,939.00
-97.06%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
969.00
32,908.00
-31,939.00
-97.06%
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0.00
0.00
0%
Raw Materials Consumed
0.00
0.00
0.00
0%
Power & Fuel Cost
0.00
0.00
0.00
0%
Employee Cost
0.00
0.00
0.00
0%
Operating Expenses
1.00
37.00
-36.00
-97.30%
General and Administration Expenses
299.00
4,969.00
-4,670.00
-93.98%
Selling and Distribution Expenses
0.00
0.00
0.00
0%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
0.00
0.00
0%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
760.00
32,144.00
-31,384.00
-97.64%
Operating Profit (PBDIT) excl Other Income
209.00
763.00
-554.00
-72.61%
Other Income
1.00
156.00
-155.00
-99.36%
Operating Profit (PBDIT)
226.00
1,220.00
-994.00
-81.48%
Interest
1.00
37.00
-36.00
-97.30%
Profit before Depriciation and Tax
0.00
0.00
0.00
0%
Depreciation
15.00
299.00
-284.00
-94.98%
Profit Before Taxation & Exceptional Items
0.00
0.00
0.00
0%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
209.00
825.00
-616.00
-74.67%
Provision for Tax
-39.00
251.00
-290.00
-115.54%
Profit After Tax
249.00
586.00
-337.00
-57.51%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
0.00
0.00
0.00
0%
Profit Available for appropriations
0.00
0.00
0.00
0%
Appropriations
0.00
0.00
0.00
0%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
26.7406
101.2211
-74.48
-73.58%
Profit And Loss - Net Sales
Net Sales 969.53 Million
in Mar 2025Figures in Million
YoY Growth in year ended Mar 2025 is 18.71% vs 2.78% in Mar 2024
Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 209.35 Million
in Mar 2025Figures in Million
YoY Growth in year ended Mar 2025 is 88.61% vs 114.79% in Mar 2024
Profit And Loss - Interest
Interest 1.26 Million
in Mar 2025Figures in Million
YoY Growth in year ended Mar 2025 is 11.50% vs 5.31% in Mar 2024
Profit And Loss - Profit After Tax
Profit After Tax 249.05 Million
in Mar 2025Figures in Million
YoY Growth in year ended Mar 2025 is 33.40% vs 164.44% in Mar 2024
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
